ERBB2 and breast carcinoma: Pyrotinib Combined with Trastuzumab, Dalpiciclib, Letrozole vs. TCbHP (Trastuzumab Plus Pertuzumab with Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast Cancer